It was perched near its all-time high and gapped down today for a volume-driven loss. Found support above its 200 DMA line in recent weeks during an orderly consolidation. Reported earnings -19% on +4% sales revenues for the Sep '21quarter versus the year ago period, raising concerns and breaking a streak of 4 strong comparisons above the +25% minimum guideline (C criteria) of the fact-based investment system.
Extended from any sound base and perched at its all-time high and on track today for its 11th gain in the span of 12 sessions. Reported earnings +139% on +39% sales revenues for the Jun '21quarter versus the year ago period, its 4th strong comparison above the +25% minimum guideline (C criteria) of the fact-based investment system.
Extended from any sound base and perched at its all-time high and on track today for its 10th gain in the span of 11 sessions. Reported earnings +139% on +39% sales revenues for the Jun '21quarter versus the year ago period, its 4th strong comparison above the +25% minimum guideline (C criteria) of the fact-based investment system.
Perched at its all-time high. Reported earnings +269% on +52% sales revenues for the Dec '20 quarter versus the year ago period, its 2nd strong comparisons. Prior quarterly sales revenues and earnings comparisons were negative and well below the +25% minimum guideline (C criteria) of the fact-based investment system.
Wedged higher last week after it reported earnings +190% on +33% sales revenues for the Sep '20 quarter versus the year ago period. Gapped down today pulling back from its all-time high. Prior quarterly sales revenues and earnings comparisons were negative and well below the +25% minimum guideline (C criteria) of the fact-based investment system.
Reported earnings -10% on +1% sales revenues for the Mar '20 quarter. Impressively rebounded near its all-time high following an abrupt retreat since noted with caution in the 3/06/20 mid-day report - "Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline."
Due to report earnings news before the open on 4/29/20. Impressively rebounded near its all-time high following an abrupt retreat since noted with caution in the 3/06/20 mid-day report - "Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline."
Impressively rebounding toward its all-time high following an abrupt retreat since last noted with caution in the 3/06/20 mid-day report - "Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline."
Retreating abruptly after a rebound near its all-time high, slumping back below its 50 DMA line ($180) today. Tested its 200 DMA line ($171.49) last week. Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline.
Rebounded near its all-time high after abruptly retreating and testing its 200 DMA line last week. Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline. Perched near its all-time high hit on the prior session with a volume-driven gain.
Perched near its all-time high after testing its 200 DMA line. Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline. Perched near its all-time high hit on the prior session with a volume-driven gain.
Reported Mar '18 quarterly financial results with earnings +31% on +18% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline. Perched near its all-time high hit on the prior session with a volume-driven gain.
Gapped up above its 50 & 200 DMA lines to quickly challenge prior chart highs after reporting its latest quarterly financial results. Unimpressive sales and earnings increases.